Amerikanische Gesellschaft für Hirudotherapie

Microvascular replantation of scalp and facial parts

Case series published in Surgical Technology International (1995)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportKlinische StudienKind GM et al. · Surgical technology international, 1995

Abstract

Replantation of fingers, hands, feet, and extremities has become a relatively common procedure. There are a number of reports of successful replants of facial parts. Since the feeding vessels are extremely small, these replants are most challenging. Venous outflow is the most common problem, and leeches and anticoagulants are commonly needed, resulting in considerable blood loss and transfusions. Nonetheless, the successful replantation of a facial part yields an aesthetic and functional result far superior to any other reconstructive option. We review our experience with 7 scalps, 4 ears, and 2 lips.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Zusammenfassung

Single-institution experience with 7 scalp, 4 ear and 2 lip microvascular replants. Venous outflow most common problem requiring leech therapy and anticoagulation, with consequent significant blood loss and transfusion needs.

Warum dies für die Hirudotherapie relevant ist

This article reviews the authors' experience with replantation of 7 scalps, 4 ears, and 2 lips, noting that venous outflow is the most common problem because the feeding vessels are extremely small. The abstract states that 'leeches and anticoagulants are commonly needed, resulting in considerable blood loss and transfusions' together as part of the management of these challenging cases. This is relevant to hirudotherapy because the abstract explicitly identifies leeches as a commonly used adjunct in facial and scalp replantation. However, the note cannot attribute the blood loss and transfusion burden to leeches alone, as the abstract assigns this to both leeches and anticoagulants combined, and no specific leech therapy protocols, outcomes, or comparative data are provided.

Zitation

Microvascular replantation of scalp and facial parts.

Kind GM et al. · Surgical technology international, 1995

DOIPubMed

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Clinical EvidenceClinical ApplicationsMicrosurgery OutcomesSurgeryAnticoagulation CompoundsHemostasisDirect Thrombin InhibitorsOtolaryngology

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.